Learn More
Cayman Chemical 4AmInobenzoIc ACD hydrazID

Supplier: Cayman Chemical 14845500 MG

A prodrug form of remogliflozin A inhibits human SGLT2 and SGLT1 (Kis 1.95 and 43.1 M respectively) inhibits increases in plasma glucose levels in a glucose tolerance test in a rat model of STZ-induced diabetes at 3 and 10 mg/ml increases fasting plasma insulin levels and reduces fasting plasma glucose and triglyceride levels as well as urinary glucose excretion in a db/db mouse model of diabetes with hyperinsulinemia and obesity at 10 and 30 mg/kg twice per day for 6 weeks
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.